Overexpression of PLCG2 and TMEM38A inhibit tumor progression in clear cell renal cell carcinoma. February 7, 2025 New Mediastinal and Hilar Lymphadenopathy After Adjuvant Pembrolizumab in a Patient ...

There is a simple discount patient access scheme for vadadustat. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact enquiries@medice ...

Department of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China College of Polymer Science and Engineering, College of Biomedical Engineering, State ...

Conclusion: We can conclude that the salivary API5, PI-PLC, and Sgsm2 can be potential biomarker candidates for CKD detection. These proteins may participate in pathways related to renal fibrosis and ...

Tubulocystic renal cell carcinoma (TC-RCC) is uncommon and is defined by exclusive tubulocystic growth. Its clinicopathology is still evolving. Twenty-eight cases of so-defined TC-RCC were studied for ...

Department of Pediatrics (J.Z., H.-C.Y., R.L.R., E.L.S., V.K.), Vanderbilt University Medical Center, Nashville, TN. Department of Pathology, Microbiology, and ...

Several risk tools can accurately predict individual baseline risks of adverse events in people with chronic kidney disease. Here, the authors examine methods of assessing risk and discuss risk ...